ImmunoGen Inks Multi-Target License Deal With ImmunoBiochem For Next-Gen Antibody-Drug Conjugates

RTTNews | 660 dni temu
ImmunoGen Inks Multi-Target License Deal With ImmunoBiochem For Next-Gen Antibody-Drug Conjugates

(RTTNews) - ImmunoGen, Inc. (IMGN) announced Monday a multi-target license and option agreement to research novel, first-in-class ADCs with privately-held biopharmaceutical company ImmunoBiochem Corp.

The collaboration will combine ImmunoGen's proprietary linker-payload technology with ImmunoBiochem's antibodies directed against specific targets.

Under the terms of the agreement, ImmunoBiochem will receive an upfront payment in exchange for providing ImmunoGen with an exclusive license to existing antibodies directed against a specific undisclosed target.

ImmunoBiochem will be eligible to receive milestone payments and royalties based on the achievement of pre-specified development, regulatory, and commercial milestones.

ImmunoGen will collaborate with ImmunoBiochem on preclinical activities and assume responsibility for the program's future clinical development and commercialization activities.

ImmunoGen will also have the option to select additional targets and antibodies to license based on certain preclinical work undertaken by ImmunoBiochem.

If ImmunoGen chooses to exercise this option, ImmunoBiochem will receive an option exercise payment and ImmunoGen will assume responsibility for all subsequent R&D associated with that program.

read more
ImmunoGen, Oxford BioTherapeutics To Collaborate To Develop Novel Antibody-Drug Conjugates

ImmunoGen, Oxford BioTherapeutics To Collaborate To Develop Novel Antibody-Drug Conjugates

ImmunoGen Inc. (IMGN), a developer of antibody-drug conjugates (ADCs) for the treatment of cancer, announced Monday a multi-year collaboration to research novel, first-in-class ADCs with clinical stage oncology company Oxford BioTherapeutics (OBT), utilizing ImmunoGen's proprietary linker-payload technology directed to novel targets identified via OBT's proprietary OGAP discovery platform.
RTTNews | 1066 dni temu
Australian Market Turns To Modest Gains In Mid-market

Australian Market Turns To Modest Gains In Mid-market

The Australian market is turning its early losses to modest gains in mid-market on Thursday, after being in the red most of the morning session, extending the gains in the previous six sessions, following the mixed cues from Wall Street overnight. The benchmark S&P/ASX 200 is staying below the 8,300 level, with gains in financial and technology stocks nearly offset by weakness in mining stocks.
RTTNews | 58 minut temu
Indian Market Likely To Open On Cautious Note

Indian Market Likely To Open On Cautious Note

Subdued GIFT Nifty, weak Asian stocks and the overnight mixed close on Wall Street point to a slightly negative start for Indian shares Thursday morning. Investors are likely to react to a slew of quarterly earnings announcements.
RTTNews | 1g 5 minut temu
Asian Markets Mixed Amid Cautious Trades

Asian Markets Mixed Amid Cautious Trades

Asian stock markets are trading mixed on Thursday, following the mixed cues from Wall Street overnight, as traders remain cautious amid continued uncertainty surrounding US President Donald Trump's trade policies, despite reaching trade deals between the U.S. and China as well as the U.S. and the U.K. Asian Markets closed mostly higher on Wednesday.
RTTNews | 1g 9 minut temu
Mild Upside Seen For Thai Stock Market

Mild Upside Seen For Thai Stock Market

The Thai stock market has alternated between positive and negative finishes through the last six trading days since the end of the five-day winning streak in which it had advanced more than 50 points or 4.3 percent. The Stock Exchange of Thailand now sits just above the 1,215-point plateau and it's poised to inch higher again on Thursday.
RTTNews | 2g 24 minut temu
Japanese Market Significantly Lower

Japanese Market Significantly Lower

The Japanese market is trading significantly lower on Thursday, extending the losses in the previous session, following the mixed cues from Wall Street overnight. The Nikkei 225 is falling below the 37,800 level, with weakness across most sectors led by index heavyweights, automakers and technology stocks.
RTTNews | 2g 45 minut temu
Indonesia Bourse May Test Resistance At 7,000 Points

Indonesia Bourse May Test Resistance At 7,000 Points

The Indonesia stock market has finished higher in two straight sessions, improving more than 150 points or 2.2 percent in that span. The Jakarta Composite Index now rests just beneath the 6,980-point plateau although investors may lock in gains on Thursday.
RTTNews | 2g 54 minut temu